CRT-800.13 Contemporary Transcatheter Aortic Valve Replacement Experience With Third-generation Balloon-expandable Versus Self-expanding Devices

Two competing TAVR technologies are approved for commercial use in the US: the balloon-expandable Sapien 3 (S3) (Edwards, Irvine, CA) and the self-expanding Evolut R (Medtronic, Minneapolis, MN). A total of 257 consecutive patients treated with S3 or Evolut R were included. Baseline demographic,